Manufacturer record
Unicure (India) Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
73 batches manufactured by Unicure (India) Ltd (Uttarakhand) were declared Not of Standard Quality between April 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
73 records linked to Unicure (India) Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
73Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
73
NSQ batches since 2019
47
Products affected
Dissolution
Most common failure
Jun 2026
Latest alert
Flagged batches per year
2019 · 42020 · 42021 · 82022 · 72023 · 82024 · 182025 · 82026 · 16
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Voglibose Tablets I.P 0.3mg | VBT1408Mfg 2026-04 · Exp 2028-03 | MisbrandedMisbranded | Andmand NicobarState lab | Jun 2026 |
| Terbutaline Sulphate, Bromhexine Hydrochloride, Guaiphenesin & Menthol Syrup | EM1LF005Mfg 2025-04 · Exp 2027-03 | ContentOther | DTL, Chennai-06State lab | Jun 2026 |
| Folic Acid Tablets IP 0.4 mg | FO1TE063Mfg 2024-11 · Exp 2027-10 | Sample does not conform to IP standards. It fails the tests Dissolution and Assay as per IP.Assay | DTL, KonniState lab | Jun 2026 |
| Atorvastatin Tablets IP 10mg | AUVT1304Mfg 2025-07 · Exp 2027-06 | Does not conform to IP Standards with respect to the Dissolution TestDissolution | Government Analyst, Food & Drugs Admn. Bambolim, GoaState lab | May 2026 |
| Aspirin Gastro-resistant Tablets IP 75 mg | ANET1283Mfg 2024-10 · Exp 2026-09 | Dissolution, Salicylic Acid and AssayAssay | DTL ThrissurState lab | May 2026 |
| Aspirin Gastro-Resistant Tablets IP 75mg | ANET1243Mfg 2024-05 · Exp 2026-04 | The Sample fails the test 'Descriptive Part, Dissolution, Salicylic Acid and Assay as per IPAssay | DTL ThiruvananthapuramState lab | Apr 2026 |
| Lactulose Solution IP 10 gm/15ml | LLS1337Mfg 2025-08 · Exp 2027-07 | The sample does not conform to IP with respect to test for Microbial contamination and Assay/content of LactuloseAssay | CDL, KolkataCDSCO lab | Mar 2026 |
| Lactulose Solution IP 10 gm/15ml | LLS1311Mfg 2025-05 · Exp 2027-04 | The sample does not conform to IP with respect to test for Microbial contamination and Assay/content of LactuloseAssay | CDL, KolkataCDSCO lab | Mar 2026 |
| Paracetamol Tablets IP 500mg | PCT1211Mfg 2024-08 · Exp 2026-07 | The sample does not confirm to IP2022 requirement withespect to Dissolution TestDissolution | DTL, Dalgate Srinagar Kashmir (J & K)State lab | Feb 2026 |
| Labetalol Tablets I.P 100mg | LA1TE011Mfg 2024-08 · Exp 2026-07 | The sample does not conform to IP Standards with respect to the test Dissolution.Dissolution | DTL ThrissurState lab | Feb 2026 |
| Fenofibrate Capsules I.P (200 mg) | FFC1201Mfg 2024-07 · Exp 2026-06 | Test for Uniformity of Weight and DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab | Feb 2026 |
| Aspirin Gastro-resistant Tablets IP 75 mg. | ANET1295Mfg 2024-12 · Exp 2026-11 | The sample does not conform to I.P.w.r.t. the tests for Dissolution in Acid Stage for Aspirin.Dissolution | RDTL, GuwahatiState lab | Feb 2026 |
| Aspirin Gastro Resistant Tablets IP 75mg | ANET 1269Mfg 2024-10 · Exp 2026-09 | Sample fails the test Dissolution' as per IP as specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Feb 2026 |
| Terbutaline Sulphate, Bromhexine Hydrochloride, Guiaphenesin & Menthol Syrup | EM1LF002Mfg 2025-04 · Exp 2027-03 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Jan 2026 |
| Iron And Folic Acid Tablets I.P. | IFAT1245Mfg 2025-03 · Exp 2027-02 | The sample does not conform to IP with respect to Description.Description | CDL, KolkataCDSCO lab | Jan 2026 |
| Ciprofloxacin Tablets I.P 500mg | CCT1303Mfg 2025-04 · Exp 2027-03 | Test for Uniformity of WeightUniformity of weight/content | RDTL, Hubli, KarnatakaState lab | Jan 2026 |
| Glipizide and Metformin Tablets USP | URDT0328Mfg 2023-01 · Exp 2025-12 | The sample does not conform to the IP with respect to Dissolution of Glipizide.Dissolution | DTL UdaipurState lab | Dec 2025 |
| Amitriptyline Tablets IP 25 mg | AMT1305Mfg 2025-05 · Exp 2027-04 | UniformityUniformity of weight/content | Drugs Testing Laboratory, Madurai-19State lab | Nov 2025 |
| Cloberasol Propionate and Salicylic Acid Ointment | 1210CSOMfg 2025-03 · Exp 2027-02 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Oct 2025 |
| Aspirin Gastro- resistant Tablets IP (150mg) | URDT2771Mfg 2023-11 · Exp 2025-10 | Assay of AspirinAssay | KarnatakaState lab | Aug 2025 |
| Paracetamol Tablets IP ( 500mg) Jan Aushadhi | PCT1208Mfg 2024-08 · Exp 2026-07 | Dissolution test of paracetamol.Dissolution | DTL Srinagar (J&K) & MDTL Kathua (J&K)State lab | Jun 2025 |
| Nitrofurantoin Tablets I.P 100 mg | NFDT1201Mfg 2024-10 · Exp 2026-09 | DissolutionDissolution | CDTL IndoreCDSCO lab | Jun 2025 |
| Labetalol Tablets IP 100mg | LA1TE012Mfg 2024-08 · Exp 2026-07 | Dissolution of Labetalol Hydrochloride TabletsDissolution | CDTL ChennaiCDSCO lab | Jun 2025 |
| Aspirin Gastro Resistant Tab IP 75 mg | ANET1235Mfg 2024-05 · Exp 2026-04 | It fails the test ?Dissolution? Specified in the laboratory protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Metoprolol Succinate Prolonged Release Tablets IP | URDT0654Mfg 2023-03 · Exp 2025-02 | It fails the test ?Assay? as per IP standards [Amendment List - 05 to IP 2022]Assay | DTL ThiruvananthapuramState lab | Dec 2024 |
| Metoprolol Succinate Prolonged Release Tablets IP | URDT0653Mfg 2023-03 · Exp 2025-02 | It fails the test ?Assay? as per IP standards [Amendment List - 05 to IP 2022]Assay | DTL ThiruvananthapuramState lab | Dec 2024 |
| Metoprolol Succinate Prolonged Release Tablets IP | URDT0652Mfg 2023-03 · Exp 2025-02 | It fails the test ?Assay? as per IP standards [Amendment List - 05 to IP 2022]Assay | DTL ThiruvananthapuramState lab | Dec 2024 |
| Aspirin Gastro- resistant Tablets IP 75mg | ANET1121Mfg 2023-08 · Exp 2025-07 | Test of Dissolution Buffer StageDissolution | CDL KolkataCDSCO lab | Dec 2024 |
| Terbutaline Sulphate, Ambroxol Hydrochloride and Guaiphenesin syrup | TM1LE027Mfg 2024-04 · Exp 2026-03 | The sample fails descriptive part for liquid oral dosage forms as per schedule V of Drugs & Cosmetics Act and Rules. The syrup contains red coloured sedimented particlesDescription | DTL ThiruvananthapuramState lab | Nov 2024 |
| Paracetamol Tablets I.P. 500mg | PCT1212Mfg 2024-08 · Exp 2026-07 | DissolutionDissolution | SDTL Agartala, TripuraState lab | Nov 2024 |
| Aspirin Gastro- resistant Tablets IP 75 mg | ANET1107Mfg 2023-07 · Exp 2024-12 | Test for Salicylic AcidOther | CDL KolkataCDSCO lab | Nov 2024 |
| Aspirin Gastro Resistant Tab IP | URDT2785Mfg 2023-11 · Exp 2025-10 | It fails the test ?Dissolution? Specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Nov 2024 |
| Paracetamol Tablets IP 650 mg [Nopain-650] | URDT2433Mfg 2023-10 · Exp 2026-09 | It fails the test ?Dissolution? Specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Oct 2024 |
| Calcium and Vitamin D3 Tablets I.P. | UDT11151Mfg 2023-08 · Exp 2025-01 | Assay of vitamin D3Assay | RDTL GuwahatiCDSCO lab | Aug 2024 |
| Sodium Valporate Gastro Resistant Tablets IP 200 mg | SVT1140Mfg 2023-09 · Exp 2026-08 | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab | Jul 2024 |
| Etamsylat Tablets 500 mg | ELT1104Mfg 2024-02 · Exp 2024-07 | DescriptionDescription | CDTL MumbaiCDSCO lab | Jun 2024 |
| Sodium Valproate Gastro-resistant Tablets IP 200 mg | SVT1136Mfg 2023-07 · Exp 2024-12 | Dissolution in ACID stageDissolution | CDTL MumbaiCDSCO lab | Mar 2024 |
| Diacerein Tablets 50 mg | DCT1102Mfg 2023-10 · Exp 2025-09 | DescriptionDescription | CDTL MumbaiCDSCO lab | Mar 2024 |
| Calcium and Vitamin D3 Tablets I.P. | UDT10723Mfg 2023-03 · Exp 2024-08 | DescriptionDescription | RDTL GuwahatiState lab | Mar 2024 |
| Oseltamivir Oral Suspension I.P. 12 mg | URDP1153Mfg 2023-05 · Exp 2024-10 | DescriptionDescription | CDL KolkataCDSCO lab | Feb 2024 |
| Ondansetron Tablets IP 4 mg | SMT1006Mfg 2022-11 · Exp 2024-10 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2024 |
| Calcium and Vitamin D3 Tablets I.P | UDT10704Mfg 2023-03 · Exp 2024-08 | DescriptionDescription | RDTL GuwahatiState lab | Jan 2024 |
| Piroxicam Tablets I.P. 20 mg, | URDT2340Mfg 2023-10 · Exp 2026-09 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2023 |
| CALCIUM AND VITAMIN D3 TABLETS I.P. | UDT10673Mfg 2023-02 · Exp 2024-07 | DescriptionDescription | RDTL GuwahatiState lab | Dec 2023 |
| Montelukast Sodium and Levocetirizine Hydrochloride Tablets I.P. | MLCT1026Mfg 2023-02 · Exp 2025-01 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2023 |
| Ramipril Tablets I.P. 5 mg. | RMFT1001Mfg 2022-06 · Exp 2024-05 | content of Ramipril (Assay)Assay | RDTL GuwahatiState lab | Oct 2023 |
| Lorazepam Tablets I.P. 2 mg | LZMT100 6Mfg 2023-02 · Exp 2025-01 | Dissolution and AssayAssay | CDTL MumbaiCDSCO lab | Aug 2023 |
| Prednisolone Tablets I.P. 5 mg | PDT1009Mfg 2022-10 · Exp 2024-09 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Jun 2023 |
| CLOZAPINE TABLETS I.P. 100 MG | CZPT1006Mfg 2022-11 · Exp 2024-04 | AssayAssay | CDTL HyderabadCDSCO lab | Jun 2023 |
| Zinc Sulphate Dispersible Tablets IP 20 mg | ZST922Mfg 2022-02 · Exp 2024-01 | AssayAssay | CDTL ChennaiCDSCO lab | Feb 2023 |
| Zinc Sulphate Dispersible Tablets IP 20 mg | ZST903Mfg 2022-01 · Exp 2023-12 | AssayAssay | CDTL ChennaiCDSCO lab | Dec 2022 |
| Zinc Sulphate Dispersible Tablets IP 20 mg | ZST922Mfg 2022-02 · Exp 2024-01 | AssayAssay | CDTL ChennaiCDSCO lab | Nov 2022 |
| Ramipril Tablets IP 5.0 mg | RMFT905Mfg 2021-10 · Exp 2023-09 | Assay of RamiprilAssay | RDTL ChandigarhCDSCO lab | Nov 2022 |
| PRE AND PROBIOTIC CAPSULES | SL1CB016Mfg 2021-11 · Exp 2023-04 | Identification and Assay of Streptococcus faecalisAssay | RDTL ChandigarhCDSCO lab | Jun 2022 |
| Methylcobalamin Tablets 500 mcg | MBT 904Mfg 2021-05 · Exp 2023-04 | AssayAssay | CDL KolkataCDSCO lab | Mar 2022 |
| Finasteride Tablets I.P. 5 mg | FNST901Mfg 2021-06 · Exp 2023-05 | DissolutionDissolution | CDL KolkataCDSCO lab | Mar 2022 |
| Aspirin Gastro- resistant Tablets I.P. 150 mg | APET901Mfg 2021-05 · Exp 2023-04 | Salicylic AcidOther | CDTL MumbaiCDSCO lab | Mar 2022 |
| Vitamin B ? Complex Tablets NFI III | VPT801Mfg 2020-06 · Exp 2021-11 | Description, Assay of Vitamin B1 & Calcium PantothenateAssay | CDL KolkataCDSCO lab | Nov 2021 |
| NORFLOXACIN TABLETS IP 400 MG | NT802Mfg 2020-10 · Exp 2022-09 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Oct 2021 |
| Atorvastatin Tablets I.P. 20 mg. | AVBT806Mfg 2020-10 · Exp 2022-09 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Aug 2021 |
| Sodium Valproate Gastro Resistant Tablets IP 200 mg | SVT871Mfg 2020-12 · Exp 2022-05 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Jul 2021 |
| Atorvastatin Tablets IP 20 mg | AVBT802Mfg 2020-07 · Exp 2022-06 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jun 2021 |
| Alusil (Aluminium, Magnesium and Simethicone Chewable Tablets I.P.) | ACT801Mfg 2020-08 · Exp 2022-07 | Assay of Polydimethyl-siloxane (Simethicone)Assay | CDL KolkataCDSCO lab | Jun 2021 |
| Nofloxacin Tablets I.P. 400 mg | NT801Mfg 2020-07 · Exp 2022-06 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | May 2021 |
| Aspirin Gastro-Resistant Tablets IP 150 mg | APET716Mfg 2019-06 · Exp 2021-05 | Test for Salicylic AcidOther | CDTL MumbaiCDSCO lab | Feb 2021 |
| SULFASALAZINE TABLETS B.P. 500 mg | SSZT718Mfg 2020-03 · Exp 2022-02 | Related SubstancesRelated substances | RDTL ChandigarhCDSCO lab | Dec 2020 |
| Telmisartan Tablets I.P. 20 mg | TLMT703Mfg 2019-07 · Exp 2021-06 | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2020 |
| Setnorm ? 4 (Ondansetron Tablets IP 4 mg) | SMT610ZMfg 2019-02 · Exp 2021-01 | DescriptionDescription | CDL KolkataCDSCO lab | Jun 2020 |
| Tranexamic Acid Tablets I.P. 500mg | TAT607Mfg 2018-10 · Exp 2020-09 | DisintegrationDisintegration | RDTL GuwahatiCDSCO lab | Apr 2020 |
| Thyrocure-50 (Thyroxine Tablets I.P. 50 mcg) | THAT616Mfg 2018-12 · Exp 2020-05 | AssayAssay | CDL KolkataCDSCO lab | Sep 2019 |
| Thyrocure-100 (Thyroxine Tablets I.P. 100 mcg) | THDT611Mfg 2018-12 · Exp 2020-05 | AssayAssay | CDL KolkataCDSCO lab | Aug 2019 |
| Thyrocure - 100 (Thyroxine Tablets I.P. 100 mcg) | THDT605Mfg 2018-07 · Exp 2019-12 | AssayAssay | CDL KolkataCDSCO lab | Apr 2019 |
| PANTOPRAZOLE GASTRO- RESISTANT TABLETS IP 40 MG | TJPE802Mfg 2018-03 · Exp 2020-02 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Apr 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.